symbol |
IVTY |
会社名 | Invuity Inc (インヴィティ) |
分野(sector) |
Health Care
ヘルスケア
|
産業(industry) |
Medical/Dental Instruments
|
業種 |
医療機器_医療用品_ディストリビュ―タ―
医療関連(Health Care)
|
概要 |
事業概要 Invuity Inc. is a United States-based medical technology company. The Company is focused on developing and marketing photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. Its Photonics technology is integrated into a family of optical waveguides including its line of reusable tissue retractors single-use handheld aspiration and universal drop-in intracavity illuminator devices. Its Photonics technology converts thermally hot concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity. Its products include Eikon Eika Eipex Eivector Breiten Saber Yankauer PhotonSaber F and Waveguide XT. Its clinical applications include women's health encompassing breast cancer and breast reconstructive surgery and thyroid surgery. Its additional applications include procedures for electrophysiology cardiothoracic and general surgery. インヴィティは、米国の医療器具メ―カ―。外科手術の切開部から低コントラストの目標物を外科医が直接可視するために、先進のフォトニクス技術を利用し、患部を照明する器具を提供する。同社「インテリジェント・フォトニクス」技術は登録商標名である。本社はサンフランシスコ。
|
本社所在地 | 444 De Haro Street San Francisco CA 94107 USA |
代表者氏名 | Gregory T. Lucier グレゴリー・T・ルシエ |
代表者役職名 | Chairman of the Board 取締役会会長 |
電話番号 | +1 415-655-2100 |
設立年月日 | 2004年 |
市場名 | NASDAQ National Market System |
ipoyear | 2015年 |
従業員数 | - |
url | www.invuity.com |
nasdaq_url | https://www.nasdaq.com/symbol/ivty |
adr_tso | ― |
EBITDA | EBITDA(百万ドル) -31.93600 |
終値(lastsale) | 7.4 |
時価総額(marketcap) | 178145217.2 |
時価総額 | 時価総額(百万ドル) 178.14520 |
売上高 | 売上高(百万ドル) 40.83400 |
企業価値(EV) | 企業価値(EV)(百万ドル) 188.87420 |
当期純利益 | 当期純利益(百万ドル) -36.46100 |
決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Invuity Inc revenues increased 6% to $20M. Net loss decreased 15% to $20.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Loss on extinguishment of debt decrease from $2.3M (expense) to $0K Selling general and administrative. decrease of 6% to $26.3M (expense). |